Ausgabe 2/2002
Inhalt (24 Artikel)
Considerations for successful transplantation of encapsulated pancreatic islets
P. de Vos, A. F. Hamel, K. Tatarkiewicz
Uncoupling protein-2: evidence for its function as a metabolic regulator
M. C. Saleh, M. B. Wheeler, C. B. Chan
A phosphodiesterase inhibitor, cilostazol, prevents the onset of silent brain infarction in Japanese subjects with Type II diabetes
T. Shinoda-Tagawa, Y. Yamasaki, S. Yoshida, Y. Kajimoto, T. Tsujino, N. Hakui, M. Matsumoto, M. Hori
The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men
H. Agersø, L. B. Jensen, B. Elbrønd, P. Rolan, M. Zdravkovic
Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy
I. M. Hogeboom van Buggenum, B. C. P. Polak, J. W. M. Reichert-Thoen, W. A. E. J. de Vries-Knoppert, V. W. M. van Hinsbergh, G. J. Tangelder
Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or Type II diabetes
M. Blüher, R. Unger, F. Rassoul, V. Richter, R. Paschke
Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes
A. J. K. Williams, P. J. Bingley, W. P. T. Moore, E. A. M. Gale
Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice
A. M. J. Shapiro, W. L. Suarez-Pinzon, R. Power, A. Rabinovitch
Syntaxin-3 and syntaxin-1A inhibit L-type calcium channel activity, insulin biosynthesis and exocytosis in beta-cell lines
Y. Kang, X. Huang, E. A. Pasyk, J. Ji, G. G. Holz, M. B. Wheeler, R. G. Tsushima, H. Y. Gaisano
Metabotropic glutamate and GABAB receptors contribute to the modulation of glucose-stimulated insulin secretion in pancreatic beta cells
N. L. Brice, A. Varadi, S. J. H. Ashcroft, E. Molnar
Kidney function and glomerulopathy over 8 years in young patients with Type I (insulin-dependent) diabetes mellitus and microalbuminuria
H.-J. Bangstad, R. Østerby, S. Rudberg, A. Hartmann, K. Brabrand, K. F. Hanssen
Kinetics of integrin expression in the mouse model of proliferative retinopathy and success of secondary intervention with cyclic RGD peptides
E. Chavakis, B. Riecke, J. Lin, T. Linn, R. G. Bretzel, K. T. Preissner, M. Brownlee, H.-P. Hammes
Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases
S. V. McLennan, D. J. Kelly, A. J. Cox, Z. Cao, J. G. Lyons, D. K. Yue, R. E. Gilbert
Polymorphism in the Calpain 10 gene influences glucose metabolism in human fat cells
J. Hoffstedt, M. Rydén, P. Löfgren, M. Orho-Melander, L. Groop, P. Arner
Adult-onset idiopathic Type I or ketosis-prone Type II diabetes: evidence to revisit diabetes classification
E. Sobngwi, J.-F. Gautier
- to: Lindner T, Cockburn BN, Bell GI (1999) Molecular genetics of MODY in Germany. Diabetologia 42: 121–123
F. Ziemssen, C. Bellanné-Chantelot, M. Osterhoff, H. Schatz, A.F.H. Pfeiffer
- to: T. J. Wilkin (2001) The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes. Diabetologia 44: 914–921
F. K. Gorus, I. Weets, D. G. Pipeleers
Complete glucokinase deficiency is not a common cause of permanent neonatal diabetes
A. L. Gloyn, S. Ellard, J. P. Shield, I. K. Temple, D. J. G. Mackay, M. Polak, T. Barrett, A. T. Hattersley
Losartan attenuates endothelial hyperpermeability responses to VPF and high glucose but not angiotensin II
I. Idris, N. Tyreman, S. Gray, R. Donnelly
Erratum to: Advanced glycation end-products: a review
R. Singh, A. Barden, T. Mori, L. Beilin